ZA200810460B - Modified beta-lactamase and method for its preparation - Google Patents

Modified beta-lactamase and method for its preparation

Info

Publication number: ZA200810460B
Authority: ZA; South Africa
Prior art keywords: lactamase; preparation; modified beta; beta; modified
Prior art date: 2006-06-21

Application number

ZA200810460A

Other languages

English (en)

Inventor

Susanna Kaeaeriaeinen

Nina Wickstrand

Pertti Koski

Original Assignee

Ipsat Therapies Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-21

Filing date

2008-12-10

Publication date

2009-12-30

2008-12-10 Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy

2009-12-30 Publication of ZA200810460B publication Critical patent/ZA200810460B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Toxicology (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

ZA200810460A 2006-06-21 2008-12-10 Modified beta-lactamase and method for its preparation ZA200810460B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FI20065431A FI119190B (fi)	2006-06-21	2006-06-21	Modifioitu beta-laktamaasi ja menetelmä sen valmistamiseksi

Publications (1)

Publication Number	Publication Date
ZA200810460B true ZA200810460B (en)	2009-12-30

Family

ID=36651526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200810460A ZA200810460B (en)	2006-06-21	2008-12-10	Modified beta-lactamase and method for its preparation

Country Status (15)

Country	Link
US (1)	US7989192B2 (xx)
EP (1)	EP2038411B1 (xx)
JP (1)	JP5306191B2 (xx)
KR (1)	KR101609243B1 (xx)
CN (1)	CN101484577A (xx)
AU (1)	AU2007262916B2 (xx)
BR (1)	BRPI0713726B1 (xx)
CA (1)	CA2659691C (xx)
ES (1)	ES2452321T3 (xx)
FI (1)	FI119190B (xx)
NO (1)	NO342006B1 (xx)
NZ (1)	NZ573696A (xx)
RU (1)	RU2009101795A (xx)
WO (1)	WO2007147945A1 (xx)
ZA (1)	ZA200810460B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20105572A0 (fi)	2010-05-24	2010-05-24	Prevab R Lcc	Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
NZ604013A (en) *	2010-06-16	2014-10-31	Abbott Lab	Comparison of protein samples
US9405884B2 (en)	2010-06-16	2016-08-02	Abbvie Inc.	Methods and systems for the analysis of protein samples
EP3156496B1 (fr) *	2011-04-21	2019-04-10	Biomérieux Inc.	Procede de detection d'au moins un mecanisme de resistance aux cephalosporines par spectrometrie de masse
US9290754B2 (en)	2014-04-17	2016-03-22	Synthetic Biologics Inc.	Beta-lactamases with improved properties for therapy
US11034966B2 (en)	2014-08-28	2021-06-15	Synthetic Biologics, Inc.	E. coli-based production of beta-lactamase
KR102467968B1 (ko)	2014-10-08	2022-11-16	신세틱 바이오로직스, 인코퍼레이티드	베타-락타마제 제형 및 이의 용도
FR3027307B1 (fr)	2014-10-16	2016-11-04	Azurrx Sas	Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant
WO2016105498A1 (en)	2014-12-23	2016-06-30	Synthetic Biologics, Inc.	Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
WO2016137993A1 (en)	2015-02-23	2016-09-01	Synthetic Biologics, Inc.	Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
KR20170122776A (ko)	2015-03-06	2017-11-06	신세틱 바이오로직스, 인코퍼레이티드	마이크로바이옴 보호를 위한 안전하고 유효한 베타-락타마제 투약
PT3420078T (pt) *	2016-02-23	2022-07-13	Da Volterra	Variantes da beta-lactamase
WO2017144495A1 (en)	2016-02-23	2017-08-31	Da Volterra	Beta-lactamase variants
KR20210040997A (ko)	2018-08-05	2021-04-14	다 볼떼라	항암제 효능의 개선 방법
CN112689506A (zh)	2018-08-05	2021-04-20	达·沃尔泰拉公司	用于治疗移植物抗宿主疾病的组合物
US20220154156A1 (en) *	2019-03-11	2022-05-19	Regents Of The University Of Minnesota	Proteins and methods for disrupting bacterial communication
WO2021137645A1 (ko) *	2019-12-30	2021-07-08	(재)씨젠의료재단	카바페넴 항생제에 대한 내성을 가지는 병원성 균주의 직접 검출 방법
EP4148136A1 (en)	2021-09-08	2023-03-15	Da Volterra	An engineered yeast cell for the delivery of antibiotic-inactivating enzymes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI920206A0 (fi)	1992-01-17	1992-01-17	Pekka Untamo Heino	Medicinsk anvaendning, medicinskt foerfarande och preparat.
FI112666B (fi)	2001-11-06	2003-12-31	Ipsat Therapies Oy	Itiöimätön Bacillus subtilis, sen valmistus ja käyttö
FR2843302B1 (fr)	2002-08-09	2004-10-22	Centre Nat Rech Scient	Forme galenique pour la delivrance colique de principes actifs

2006
- 2006-06-21 FI FI20065431A patent/FI119190B/fi not_active IP Right Cessation
2007
- 2007-06-19 CN CNA200780023477XA patent/CN101484577A/zh active Pending
- 2007-06-19 WO PCT/FI2007/050372 patent/WO2007147945A1/en not_active Ceased
- 2007-06-19 AU AU2007262916A patent/AU2007262916B2/en active Active
- 2007-06-19 BR BRPI0713726-5A patent/BRPI0713726B1/pt active IP Right Grant
- 2007-06-19 CA CA2659691A patent/CA2659691C/en active Active
- 2007-06-19 JP JP2009515904A patent/JP5306191B2/ja active Active
- 2007-06-19 KR KR1020097001283A patent/KR101609243B1/ko active Active
- 2007-06-19 ES ES07765926.6T patent/ES2452321T3/es active Active
- 2007-06-19 NZ NZ573696A patent/NZ573696A/en not_active IP Right Cessation
- 2007-06-19 RU RU2009101795/10A patent/RU2009101795A/ru not_active Application Discontinuation
- 2007-06-19 US US12/304,874 patent/US7989192B2/en active Active
- 2007-06-19 EP EP07765926.6A patent/EP2038411B1/en active Active
2008
- 2008-12-10 ZA ZA200810460A patent/ZA200810460B/xx unknown
2009
- 2009-01-19 NO NO20090297A patent/NO342006B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2007147945A1 (en)	2007-12-27
BRPI0713726A2 (pt)	2012-10-30
WO2007147945A8 (en)	2009-07-30
CN101484577A (zh)	2009-07-15
CA2659691A1 (en)	2007-12-27
AU2007262916A1 (en)	2007-12-27
EP2038411A1 (en)	2009-03-25
BRPI0713726B1 (pt)	2023-01-10
AU2007262916B2 (en)	2013-12-05
FI20065431L (fi)	2007-12-22
US7989192B2 (en)	2011-08-02
JP2009540814A (ja)	2009-11-26
EP2038411A4 (en)	2010-04-07
NZ573696A (en)	2011-09-30
EP2038411B1 (en)	2014-02-26
KR101609243B1 (ko)	2016-04-05
CA2659691C (en)	2015-05-19
RU2009101795A (ru)	2010-07-27
JP5306191B2 (ja)	2013-10-02
ES2452321T3 (es)	2014-03-31
NO342006B1 (no)	2018-03-12
NO20090297L (no)	2009-01-19
FI119190B (fi)	2008-08-29
KR20090046787A (ko)	2009-05-11
FI20065431A0 (fi)	2006-06-21
US20090181004A1 (en)	2009-07-16

Publication	Publication Date	Title
ZA200810460B (en)	2009-12-30	Modified beta-lactamase and method for its preparation
TWI340555B (en)	2011-04-11	Ad convertere and adconversion method
ZA200805990B (en)	2009-04-29	New method and system
IL192419A0 (en)	2011-08-01	Anti-ephb4 antibodies and methods using same
GB201109817D0 (en)	2011-07-27	System and method
EP2069901A4 (en)	2010-10-06	METHOD AND SYSTEM FOR SELECTION
GB0601961D0 (en)	2006-03-15	Method
EP2121756A4 (en)	2011-08-31	ANTIBODIES AND PROCESS FOR THEIR PREPARATION AND USE
PL1900949T3 (pl)	2019-07-31	Element poślizgowy i sposób jego wytwarzania
IL247957A0 (en)	2016-11-30	Anti-ephrinb2 antibodies and methods of using them
EP1972615A4 (en)	2011-04-13	CYCLOALCANECARBOXAMIDE DERIVATIVE AND METHOD FOR PRODUCING THE SAME
PL2132251T3 (pl)	2017-05-31	Kompozycja i sposób
GB0603008D0 (en)	2006-03-29	Method
GB201008346D0 (en)	2010-07-07	Methods and compounds for phototransfer
GB0601699D0 (en)	2006-03-08	Method
GB0602449D0 (en)	2006-03-22	Chuck and method
PT2122108T (pt)	2016-12-09	Configuração e método de perfuração
GB0608966D0 (en)	2006-06-14	Method and product
GB0620930D0 (en)	2006-11-29	Composition and method for use thereof
GB0625208D0 (en)	2007-01-24	Composition and method
EP2062060A4 (en)	2017-07-26	Measuring head and measuring method
GB0600261D0 (en)	2006-02-15	Composition and method
ZA200806053B (en)	2009-12-30	Anti-EphB4 antibodies and methods using same
GB0621272D0 (en)	2006-12-06	Assay and method
GB0604315D0 (en)	2006-04-12	Composition and method